日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy

撤稿声明:针对内源性逆转录病毒的抗体可促进肺癌免疫疗法

Ng, Kevin W; Boumelha, Jesse; Enfield, Katey S S; Almagro, Jorge; Cha, Hongui; Pich, Oriol; Karasaki, Takahiro; Moore, David A; Salgado, Roberto; Sivakumar, Monica; Young, George; Molina-Arcas, Miriam; de Carné Trécesson, Sophie; Anastasiou, Panayiotis; Fendler, Annika; Au, Lewis; Shepherd, Scott T C; Martínez-Ruiz, Carlos; Puttick, Clare; Black, James R M; Watkins, Thomas B K; Kim, Hyemin; Shim, Seohee; Faulkner, Nikhil; Attig, Jan; Veeriah, Selvaraju; Magno, Neil; Ward, Sophia; Frankell, Alexander M; Al Bakir, Maise; Lim, Emilia L; Hill, Mark S; Wilson, Gareth A; Cook, Daniel E; Birkbak, Nicolai J; Behrens, Axel; Yousaf, Nadia; Popat, Sanjay; Hackshaw, Allan; Hiley, Crispin T; Litchfield, Kevin; McGranahan, Nicholas; Jamal-Hanjani, Mariam; Larkin, James; Lee, Se-Hoon; Turajlic, Samra; Swanton, Charles; Downward, Julian; Kassiotis, George

Preoperative Circulating Tumor DNA Detection and Risk Stratification in Esophageal Squamous Cell Carcinoma

食管鳞状细胞癌术前循环肿瘤DNA检测及风险分层

Hong, Tae Hee; Jeong, Jun-Gi; Park, Seong Yong; Park, Byung Jo; Kyung, Dongsoo; Kim, Hwang-Phil; Zhu, Jingjun; Yang, Young Ho; Kim, Ha Eun; Lee, Chang Young; Lee, Jin Gu; Jeon, Yeong Jeong; Lee, Junghee; Cho, Jong Ho; Choi, Yong Soo; Shim, Young Mog; Lee, Se-Hoon; Kim, Dae Joon; Kim, Hong Kwan

RIN3 mutations impairing binding of the Alzheimer's disease-associated protein BIN1 lead to RAB5 hyperactivation and endosomal pathology.

RIN3 突变会损害阿尔茨海默病相关蛋白 BIN1 的结合,导致 RAB5 过度激活和内体病变。

Maaser-Hecker Anna K, Zellmer Jacob C, Kim Michelle, Bakiasi Grisilda, Maiti Amit K, Curtat Matea P C, Choi Se Hoon, Prokopenko Dmitry, Tanzi Rudolph E, Bhattacharyya Raja

Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study

Simlukafusp alfa (FAP-IL2v) 联合阿特珠单抗,加或不加贝伐珠单抗,用于治疗不可切除的转移性肾细胞癌:一项随机、开放标签的 Ib 期研究

Perez-Gracia, Jose Luis; Mellado, Begoña; Hansen, Aaron Richard; Alonso-Gordoa, Teresa; Gomez-Roca, Carlos; Løvendahl Eefsen, Rikke; Negrier, Sylvie; Suárez, Cristina; Lee, Jae-Lyun; Hussain, Arif; Pedrazzoli, Paolo; Moreno, Victor; Rodriguez-Vida, Alejo; Sosman, Jeffrey Alan; Waddell, Tom; Bedke, Jens; Park, Se Hoon; Sznol, Mario; Spychaj, Lukasz; Andersson, Emilia; Julien-Laferriere, Alice; Cheng, Wei-Yi; Watson, Carl; Silva, Ana Patricia; Heichinger, Christian; Staedler, Nicolas; Sleiman, Nassim; Dejardin, David; Boetsch, Christophe; Evers, Stefan; Vardar, Taner; Ardeshir-Tandon, Caroline; Dorado Pérez, Jorge; Charo, Jehad; Keshelava, Nino; Kraxner, Anton; Teichgräber, Volker; Powles, Thomas

Loss of HuD Sensitizes Neuroblastoma Cells to Palmitate-Driven Stress-Induced Premature Senescence via PPARα Downregulation and FAO Impairment.

HuD 的缺失通过 PPARα 下调和 FAO 损伤使神经母细胞瘤细胞对棕榈酸酯驱动的应激诱导的过早衰老更加敏感。

Ryu Seungyeon, Seo Jiyoon, Sim Ye Eun, Jung Se Hoon, Zhang Wei, Jeong Seung Min, Lee Eun Kyung

Harnessing the Gut Microbiota to Improve Cancer Immunotherapy: Focus on Lung Cancer

利用肠道菌群改善癌症免疫疗法:聚焦肺癌

Park, Uni; Heo, Jun-Yeong; Chun, Seung-Min; Lee, June-Chul; Lee, Se-Hoon; Lee, Seung-Woo

Time- and Cost-Efficient, Minimally Invasive Comparative Assessment of Implant Stability: Reliability and Inter-Examiner Agreement of IST Versus ISQ Across Different Bone Quality Models

省时省钱、微创的种植体稳定性比较评估:不同骨质量模型下IST与ISQ的可靠性和检查者间一致性

Kim, Sung-Joon; Kahm, Se Hoon

Clinical Relevance of Starting Alectinib at a Reduced Dose in Patients with ALK-Positive Non-Small Cell Lung Cancer

在ALK阳性非小细胞肺癌患者中,以较低剂量开始使用阿来替尼的临床意义

Kim, Junkyu; Kim, Min-Ji; Kim, Jinyong; Park, Sehhoon; Jung, Hyun Ae; Lee, Se-Hoon; Ahn, Jin Seok; Ahn, Myung-Ju; Sun, Jong-Mu

Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma in the East Asian Subgroup of the Phase 3 KEYNOTE-564 Study

KEYNOTE-564 III期研究东亚亚组中肾细胞癌辅助治疗帕博利珠单抗与安慰剂的比较

Park, Se Hoon; Chang, Yen-Hwa; Lee, Jae Lyun; Choueiri, Toni K; Kimura, Go; Chung, Jinsoo; Masumori, Naoya; Nishimura, Kazuo; Kato, Minoru; Kato, Haruaki; Numakura, Kazuyuki; Chang, Chao-Hsiang; Anai, Satoshi; Tsunemori, Hiroyuki; Chen, Chung-Hsin; Lin, Jianxin; Elfiky, Aymen; Burgents, Joseph E; Kitamura, Hiroshi

Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma

EV-302/KEYNOTE-A39 泛亚洲亚组分析:一项评估恩福妥单抗和帕博利珠单抗治疗未经治疗的晚期尿路上皮癌患者的 3 期研究

Kikuchi, Eiji; Van der Heijden, Michiel S; Valderrama, Begoña P; Gupta, Shilpa; Bedke, Jens; Shin, Sang Joon; Li, Jian-Ri; Guo, Jun; Danchaivijitr, Pongwut; Kanesvaran, Ravindran; Park, Se Hoon; Su, Wen-Pin; Kandori, Shuya; Bae, Woo Kyun; Wong, Alvin; Gorla, Seema; Bavle, Abhishek; Yu, Xuesong; Lu, Yi-Tsung; Powles, Thomas